Preliminary Data Regarding the Nontuberculous Mycobacteria Isolation from Clinical Specimens, from Human PatienTS, in Iași County

Autor: Ioana Alexandra RĂȚOI (ANTON), Luciana Alexandra CRIVEI, Luanda Elena OȘLOBANU, Daniela DICULENCU, Gheorghe SAVUȚA

Publikováno v: Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca: Veterinary Medicine, Vol 75, Iss 1, Pp 141-144 (2018)

The nontuberculous mycobacteria (NTM) represents a large group ofubiquitous environmental mycobacterial species, with more than 160 members that can pose a threat for human health, especially for the immunocompromised hosts. The aim of the current st

Externí odkaz: https://doaj.org/article/e959b2e679384e5f9f2fa775d5e1f847

New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation

Autor: Carmen Lăcrămioara Zamfir, Cătălina Elena Lupușoru, Sangram Keshari Samal, Oana Maria Dragostin, Cristina Mihaela Ghiciuc, Daniela Diculencu, Luminița Georgeta Confederat, Rodica Tatia, Ionut Dragostin, Maria Drăgan, Saumya Dash

Publikováno v: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 137

Tuberculostatic drugs are the most common drug groups with global hepatotoxicity. Awareness of potentially severe hepatotoxic reactions is vital, as hepatic impairment can be a devastating and often fatal condition. The treatment problems that may ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1168e2f575fc379156f0132312bc2c
https://pubmed.ncbi.nlm.nih.gov/31252051

Detection of first and second line drug resistance mutations from multi drug resistantmycobacterium tuberculosisstrains by Ion Torrent whole genome sequencing (WGS)

Autor: Simona Peter, Ionut Pavel, Florin Rusu-Cordunean, Daniela Diculencu, Ina Iuliana Macovei, Bogdan Grigoriu

Publikováno v: 10.2 Tuberculosis.

Treatment success in patients infected with multi-drug resistant strains tuberculosis (MDR-TB) depends on the proper drug choice. Molecular biology methods allowed the identification of the genomic resistance profile of Mycobacterium tuberculosis wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42b84809d8f52b0455512c96ddbfd84b
https://doi.org/10.1183/13993003.congress-2016.pa1910

Synthesis and antituberculosis action of some new pyruvic acid derivatives

Autor: Margareta, Ungureanu, Daniela, Diculencu, Cristina, Archip

Publikováno v: Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 112(3)

The present paper studies the synthesis and activity of 12 new azoic derivatives against Mycobacterium tuberculosis.In order to obtain new antituberculosis substances, we studied 6 thiadiazolic derivatives and 6 triazolic derivatives of pyruvic acid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d7fbd76dc6cd2eb64c8b281b3239711b
https://pubmed.ncbi.nlm.nih.gov/20201282

[Comparative evaluation between MB/BacT system and Löwenstein-Jensen solid culture media for mycobacterial isolation]

Autor: Bogdan Dragoş, Grigoriu, Carmen, Grigoriu, Cristian, Cojocaru, Traian, Mihăescu, Daniela, Diculencu

Publikováno v: Pneumologia (Bucharest, Romania). 56(2)

Tuberculosis is a public health issue in both developed and developing countries. Success of the treatment depend on the identification of patients with positive sputum smears, rapid confirmation of diagnosis in patients with negative microscopy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59494c9da3bc318dc3626bbe1ead5d86
https://pubmed.ncbi.nlm.nih.gov/18019750